Proactiveinvestors USA & Canada Valeo Pharma Inc. https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Valeo Pharma Inc. RSS feed en Thu, 24 Sep 2020 04:31:48 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Valeo Pharma begins trading on the OTCQB Market https://www.proactiveinvestors.com/companies/news/929823/valeo-pharma-begins-trading-on-the-otcqb-market-929823.html Wed, 23 Sep 2020 15:40:00 -0400 https://www.proactiveinvestors.com/companies/news/929823/valeo-pharma-begins-trading-on-the-otcqb-market-929823.html Valeo Pharma closes $6.9 million financing to support launch of new specialty pharmaceutical products https://www.proactiveinvestors.com/companies/news/928799/valeo-pharma-closes-69-million-financing-to-support-launch-of-new-specialty-pharmaceutical-products-928799.html Thu, 10 Sep 2020 20:50:00 -0400 https://www.proactiveinvestors.com/companies/news/928799/valeo-pharma-closes-69-million-financing-to-support-launch-of-new-specialty-pharmaceutical-products-928799.html Valeo Pharma closes oversubscribed bought deal bringing in 6.9 million to treasury https://www.proactiveinvestors.com/companies/news/928813/valeo-pharma-closes-oversubscribed-bought-deal-bringing-in-69-million-to-treasury-928813.html Thu, 10 Sep 2020 20:22:00 -0400 https://www.proactiveinvestors.com/companies/news/928813/valeo-pharma-closes-oversubscribed-bought-deal-bringing-in-69-million-to-treasury-928813.html Valeo Pharma gets approval from Health Canada to sell its immune support Hesperco capsules https://www.proactiveinvestors.com/companies/news/928254/valeo-pharma-gets-approval-from-health-canada-to-sell-its-immune-support-hesperco-capsules-928254.html ]]> Thu, 03 Sep 2020 17:58:00 -0400 https://www.proactiveinvestors.com/companies/news/928254/valeo-pharma-gets-approval-from-health-canada-to-sell-its-immune-support-hesperco-capsules-928254.html Valeo Pharma wins Health Canada natural product licence for its immune support Hesperco capsules https://www.proactiveinvestors.com/companies/news/928231/valeo-pharma-wins-health-canada-natural-product-licence-for-its-immune-support-hesperco-capsules-928231.html Thu, 03 Sep 2020 12:35:00 -0400 https://www.proactiveinvestors.com/companies/news/928231/valeo-pharma-wins-health-canada-natural-product-licence-for-its-immune-support-hesperco-capsules-928231.html Valeo Pharma applies to Health Canada to licence immune system support product Hesperco https://www.proactiveinvestors.com/companies/news/927401/valeo-pharma-applies-to-health-canada-to-licence-immune-system-support-product-hesperco-927401.html Mon, 24 Aug 2020 16:39:00 -0400 https://www.proactiveinvestors.com/companies/news/927401/valeo-pharma-applies-to-health-canada-to-licence-immune-system-support-product-hesperco-927401.html Valeo Pharma files for natural product licence with Health Canada for its bioflavonoid formulation Hesperco https://www.proactiveinvestors.com/companies/news/927373/valeo-pharma-files-for-natural-product-licence-with-health-canada-for-its-bioflavonoid-formulation-hesperco-927373.html Mon, 24 Aug 2020 12:35:00 -0400 https://www.proactiveinvestors.com/companies/news/927373/valeo-pharma-files-for-natural-product-licence-with-health-canada-for-its-bioflavonoid-formulation-hesperco-927373.html Valeo Pharma unveils $6 million financing as it works to commercialize anti-tumor agent Yondelis https://www.proactiveinvestors.com/companies/news/927279/valeo-pharma-unveils-6-million-financing-as-it-works-to-commercialize-anti-tumor-agent-yondelis-927279.html Fri, 21 Aug 2020 12:55:00 -0400 https://www.proactiveinvestors.com/companies/news/927279/valeo-pharma-unveils-6-million-financing-as-it-works-to-commercialize-anti-tumor-agent-yondelis-927279.html Valeo Pharma begins commercialization of Yondelis, a treatment for soft tissue sarcoma https://www.proactiveinvestors.com/companies/news/926498/valeo-pharma-begins-commercialization-of-yondelis-a-treatment-for-soft-tissue-sarcoma-926498.html Wed, 12 Aug 2020 12:52:00 -0400 https://www.proactiveinvestors.com/companies/news/926498/valeo-pharma-begins-commercialization-of-yondelis-a-treatment-for-soft-tissue-sarcoma-926498.html Valeo Pharma starts commercialization process of antitumor agent Yondelis in Canada https://www.proactiveinvestors.com/companies/news/926493/valeo-pharma-starts-commercialization-process-of-antitumor-agent-yondelis-in-canada-926493.html Wed, 12 Aug 2020 12:45:00 -0400 https://www.proactiveinvestors.com/companies/news/926493/valeo-pharma-starts-commercialization-process-of-antitumor-agent-yondelis-in-canada-926493.html